Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ) has issued an update.
AstraZeneca Pharma India Limited has announced the appointment of Mr. Harish Dash as Senior Director, Commercial IT & Digital, effective March 3, 2025. With over 24 years of experience in technology and strategy, Mr. Dash is expected to enhance the company’s digital capabilities and drive business growth through innovative digital solutions, potentially strengthening AstraZeneca’s market position and operational excellence.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development and commercialization of prescription medicines. The company is known for its work in areas such as oncology, cardiovascular, renal, and metabolism, as well as respiratory diseases, aiming to improve patient outcomes through innovative treatments.
YTD Price Performance: -4.69%
Average Trading Volume: 1,383
Current Market Cap: 171.7B INR
Find detailed analytics on ASTRAZEN stock on TipRanks’ Stock Analysis page.